POM-V Prescription Required Companion Animal

Emeprid 1 mg/ml Oral Solution for Dogs and Cats

Active ingredient: Metoclopramide Hydrochloride

Form

Liquid

Species

Cats Dogs

Manufacturer

Ceva Sante Animale

VMD MA No.

14966/3094

What it's used for

Symptomatic treatment of vomiting and reduced gastro-intestinal motility associated with gastritis, pyloric spasm, chronic nephritis and digestive intolera...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Metoclopramide Hydrochloride

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Emeprid 1 mg/ml Oral Solution for Dogs and Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Symptomatic treatment of vomiting and reduced gastro-intestinal motility associated with
gastritis, pyloric spasm, chronic nephritis and digestive intolerance to some drugs.

as either:
2.5 to 5.0 mg/10 kg (equivalent to 2.5 to 5 ml/10 kg), twice daily
or
1.7 to 3.3 mg/10 kg (equivalent to 1.7 to 3.3 ml/10 kg), three times daily.
Oral administrations can be repeated with interval of 6 hours.

Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Do not use in cases of gastro-intestinal perforation or obstruction.
Do not use in the case of gastro-intestinal haemorrhage.

Dogs, cats:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Agitation
, Aggression
, Vocalisation
Ataxia
, Abnormal movement
, Tremor
,
Prostration
1
These observed extrapyramidal effects are transient and disappear when treatment is
stopped.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.

None.

Special precautions for safe use in the target species
The dosage must be adapted in animals with renal or hepatic insufficiency (due to an
increase in the risk of side effects). Avoid administration to animals with epilepsy. The
dosage should be carefully observed, especially in cats and small breed dogs.
Following prolonged vomiting, consideration should be given to fluid and electrolyte
replacement therapy.
In case of vomiting after intake of the oral solution, maintain the usual interval between two
administrations before administering the product again.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In case of accidental ingestion, especially by children, seek medical advice immediately
and show the package leaflet or the label to the physician.
In case of accidental exposure by spillage onto the skin or eyes, wash immediately with
abundant water. If adverse effects appear, seek medical advice immediately and show
the package leaflet or the label to the physician.
Wash hands after administration to the animal.
Special precautions for the protection of the environment
Not applicable.

In cases of gastritis, avoid the co-administration of anticholinergic drugs (atropine) as they
may counteract the effects of metoclopramide on gastrointestinal motility.
In cases of simultaneous diarrhoea, there is no contra-indication to the use of
anticholinergic drugs.
Concurrent use of metoclopramide with neuroleptics derivated from phenothiazine
(acepromazine) and butyrophenones increases the risk of extrapyramidal effects (see
section 3.6).
Metoclopramide can potentiate the action of central nervous system depressants. If used
concurrently, it is advised to use the lowest dosage of metoclopramide to avoid excessive
sedation.

This veterinary medicinal product does not require any special storage conditions.

or
1.7 to 3.3 mg/10 kg (equivalent to 1.7 to 3.3 ml/10 kg), three times daily.
Oral administrations can be repeated with interval of 6 hours.
3.10 Symptoms of overdose (and where applicable, emergency procedures, and
antidotes)
Most of the clinical signs reported after an overdosage are well known extrapyramidal side
effects (see section 3.6).
In the absence of a specific antidote, it is recommended to offer a calm environment to the
animal until extrapyramidal side effects disappear.
Metoclopramide being rapidly metabolised and eliminated, side effects generally
disappear quickly.
3.11.Special restrictions for use and special conditions for use, including
restrictions on the use of antimicrobial and antiparasitic veterinary medicinal
products in order to limit the risk of development of resistance
Not applicable.
3.12 Withdrawal periods
Not applicable.
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.